Core One Labs Inc. - CEO, Joel Shacker
CEO, Joel Shacker
Source: YouTube
  • Core One Labs Inc. (COOL) acquires all the outstanding share capital of Awakened Biosciences Inc. for $9.76 million
  • Core One and Awakened are psychedelics research and technology companies
  • Core One Labs has issued seven million common shares and 1.4 million share purchase warrants at a price of $1.15 per share
  • The company has also issued 140,600 common shares to certain third parties
  • Core One Labs Inc. (COOL) is up 10 per cent and is trading at $1.21 per share as of 12:23 p.m. EST

Core One Labs Inc. (COOL) has acquired all outstanding share capital of Awakened Biosciences for $9.76 million.

Core One and Awakened are psychedelics research and technology companies. Awakened’s production methods can produce psychedelic compounds at scale for reduced costs.

Core One Labs has issued seven million common shares and 1.4 million share purchase warrants at a price of $1.15 per share until February 4, 2024.

This entitles the holders to acquire an equivalent number of common shares of Core One Labs.

The company has also issued 140,600 common shares to certain third parties involved in the transaction.

The transaction was completed in connection to a share purchase agreement.

Acquiring these shares allows the expansion of Core One’s portfolio of subsidiaries specializing in psychedelic compounds, and the methods its scientists can employ.

Awakened’s novel production methods require filing three provisional patent applications for the protection of its proprietary technologies.

Joel Shacker, Core One CEO, stated,

“With the addition of Awakened to the Core One family, the company has increased expansion opportunities, furthered its psychedelic products portfolio, and secured potential for immediate revenue generation.”

Core One Labs Inc. (COOL) is up 10 per cent and is trading at $1.21 per share as of 12:23 p.m. EST.



More From The Market Online

Optimi Health certified for increased MDMA capsule dosages

Optimi Health (CSE:OPTI) confirms its formulated MDMA meets Good Manufacturing Practice specifications after third-party laboratory testing.

Optimi Health makes first international MDMA shipment

Optimi Health (CSE:OPTI) makes its first international shipment of MDMA to The Institute for Psychedelic Research at Tel Aviv University.

Red Light Holland and Costco Canada partner on mushroom kits

Red Light Holland (CSE:TRIP) partners with Costco Canada to launch Mega Block, a 2-kilogram home-grow mushroom kit, in late May.

CCrest Labs receives Red Light Holland’s largest psilocybin order

Red Light Holland's (CSE:TRIP) largest shipment to date of 5 kilograms of psilocybin truffles has been received by CCrest Labs in Montreal.